Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
7 June 2024
Cancers Receives an Increased CiteScore of 8.0
We are pleased to inform you that Cancers (ISSN: 2072-6694) has received a heightened CiteScore of 8.0.
CiteScore provides transparent metrics that enable well-informed publishing strategies, library collection development, and the benchmarking of journal performance. It is now a standard citation metric alongside SNIP and SJR that gives an up-to-date view of a journal’s impact.
The 2023 CiteScore provides an assessment of the scientific influence of journals in the 2020 to 2023 period.
This is a reflection of the excellent performance, support, and dedication of all journal editors, reviewers, authors, and readers.
Cancers’ CiteScore ranks as follows:
- Q1 (81 out of 404) in the “Oncology” category;
- Q2 (72 out of 230) in the “Cancer Research” category.
For more journal statistics, please visit https://www.mdpi.com/journal/cancers/stats.
Thank you to everyone who has contributed to the journal.
